This content is machine translated α-Synuclein immunoreactivity at the enteric nervous system. Biomarkers for prodromal parkinsonism syndrome? Purpose: This multicenter controlled observational study investigates α-synuclein immunoreactivity at the enteric nervous system in patients with idiopathic REM sleep behavior disorder (iRBD) and controls as a possible biomarker for…
View Post 2 min This content is machine translated Parkinson's Coffee consumption and risk of levodopa-induced dyskinesias. Purpose: To investigate a possible association between coffee consumption and the risk of levodopa-induced dyskinesia in patients with Parkinson’s disease.
View Post 5 min This content is machine translated Cavernomas in the brain stem Perioperative imaging and microsurgical strategies. Case report: In 2011, a 50-year-old patient was diagnosed with a cavernoma of almost 2 cm in the area of the pons, after passive mild sensory disturbances of the right side…
View Post 8 min This content is machine translated Amyotrophic lateral sclerosis Update on diagnostics and therapy of ALS Life expectancy and quality of life of ALS patients can be improved with modern therapy. The patient’s will is paramount and must always be determined. There is no news on…
View Post 7 min This content is machine translated Diagnostic options for acute and chronic vertigo “Everything is spinning!” In the case of the leading symptom of dizziness, a structured procedure incl. targeted questioning of the duration and frequency of episodes as well as provocation factors and a focused…
View Post 3 min This content is machine translated Annual Meeting of the Brain Stroke Society Cerebral amyloid angiopathy – a not so rare cause of cerebral hemorrhage At this year’s annual meeting of the Brain Stroke Society in Aarau, Prof. David Werring, UCL, Institute of Neurology, London (UK), provided information on cerebral amyloid angiopathy (CAA). This disease…
View Post 7 min This content is machine translated Multiple Sclerosis Symposium in Bern How to increase the benefit of therapy and minimize the risk? At the Multiple Sclerosis Symposium in Bern, experts took a close look at current symptomatic and disease-modifying therapy. With the rapid advances made in recent years, it is important to…
View Post 4 min This content is machine translated Case reports suggest possible efficacy A Swiss drug with Tibetan background against restless legs syndrome? In addition to the official and approved indications for Padma 28, a herbal medicine manufactured in Switzerland and based on a Tibetan formulation, there are indications for other possible uses.…
View Post 4 min This content is machine translated Annual meeting of the neurological society Headaches: sometimes anything but trivial The annual meeting of the Swiss Neurological Society was held in Bern at the end of October 2015. In a series of lectures, various causes of headaches were presented and…
View Post 7 min This content is machine translated Diagnose and treat in time Neurogenic bladder dysfunction in multiple sclerosis. Patients with MS should be educated early about potential and common bladder disorders. The problem awareness of treating physicians should be raised so that adequate diagnostics and therapy can be…
View Post 7 min This content is machine translated ADHD in adults Update on clarification and treatment options With the introduction of the DSM-5 and the accompanying expansion of the inclusion criteria, the differentiated clinical diagnosis takes on even greater importance. This is against the background of missing…
